Latest News in the pharma Industry
Top Stories
Mylan finalizes settlement agreement on Medicaid rebate classification for EpiPen Auto-Injector
17 Aug 2017
Mylan will reclassify EpiPen Auto-Injector for purposes of the Medicaid Drug Rebate Program and pay the rebate applicable to innovator products effective as of 1 April 2017.
Read more
Lonza acquires Micro-Macinazione to create the leader in micronization capacity and capabilities
4 Aug 2017
Bolt-on acquisition adds value to other areas of Lonza’ business, including Health & Nutrition ingredients and excipients.
Read more
Artificial intelligence to discover drugs in a multi-year multimillion dollar deal
26 Jul 2017
AI thought to have massive potential to reduce the cost associated with the discovery of new drugs.
Read more
Merck and Pfizer collaborate with Corning to modernize pharmaceutical glass packaging
23 Jul 2017
Collaborations result in development of Corning Valor Glass.
Read more
GSK delivers double-edged sword
19 Jul 2017
Company announces investments, the sale of several products and a proposal to close a UK manufacturing site.
Read more
Researchers develop microneedle patch for flu vaccination
28 Jun 2017
The patch can dramatically reduce the cost of vaccination, as self-administration can eliminate the need to have health workers oversee the process.
Read more
Takeda terminates plans for Vaxem Hib launch in Japan
11 May 2017
Discontinuation due to the vaccine supplier’s (GSK) decision to discontinue global production.
Read more
Croda celebrates EXCiPACT Certification across all leading excipient sites
10 May 2017
Status marks the company as the first multi-site excipient supplier to achieve global EXCiPACT accreditation across its production facilities.
Read more
Chemotherapy as a tablet instead of an intravenous infusion
28 Mar 2017
New production method for solid dispersions of docetaxel and paclitaxel.
Read more
Landmark outcomes study shows that Repatha decreases LDL-C to unprecedented low levels
17 Mar 2017
Amgen has announced that the 27,564-patient Repatha (evolocumab) cardiovascular outcomes study, FOURIER, established for the first time that maximally reducing low-density lipoprotein cholesterol (LDL-C) levels with Repatha, beyond what is possible wit...
Read more
Mylan announces global settlement and license Agreements with Genentech and Roche on Herceptin
13 Mar 2017
Settlement provides Mylan with global licenses for its trastuzumab product.
Read morePharma's most innovative companies; the 2017 ranking
28 Feb 2017
Innovation is being driven increasingly by smaller, possibly more agile, companies.
Read more